From her laboratory she is working to obtain biological reagents capable of combating the different dengue proteins in order to obtain a vaccine candidate against this disease.
“Obtaining this vaccine candidate is a complicated process because we are talking about four proteins that are complex, although we have already obtained a series of biological reagents, which have already been evaluated. We are contributing to different divisions of the CIGB in Havana and undoubtedly it is a great challenge, but we are thinking big and I am sure we will succeed,” said Dorta Hernandez.
The doctor’s work was decisive in the creation of Cuban biologics against COVID and she tells Radio Sancti Spíritus that she was a bundle of nerves in her beginnings as a researcher at the CIGB, back in 1997.
“In the middle of the pandemic, we were given the task of obtaining the monoclonal antibodies related to the proteins and in record time we obtained a range of these biological reagents that were indispensable at that time and today are still used for quality control in the intermediate process to obtain the vaccine,” she added.
Fortunately, Dayamí’s mind does not rest even in the tranquility of her home and confesses that 24 hours a day are not enough to do research for the good of humanity.
Dayamí Dorta Hernández, Doctor of Veterinary Medicine, one of the researchers at the Center for Genetic Engineering and Biotechnology of Sancti Spíritus, where she is working on the creation of a vaccine candidate against dengue fever.
Escambray reserves the right to publish comments.